Special Issue "Soft Tissue and Bone Sarcoma"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (31 January 2013)
Dr. Edwin Choy
Division of Hematology and Oncology, Massachusetts General Hospital, P.O. Box 226, Boston, MA 02114, USA
Phone: +1 617 643 0230
Fax: +1 617 643 1915
Interests: sarcoma; osteosarcoma; Ewing's sarcoma; giant cell tumor; chordoma
Soft Tissue and Bone Sarcomas disproportionately affect children, adolescents, and young adults. Although considered a rare disease, sarcomas continue to have a devastating effect on these patients and their loved ones, and their impact on our society far exceed their relatively low prevalence. Because of its rarity and heterogeneity, clinical decision making on management of sarcomas are often individualized and without a consensus treatment strategy. Furthermore, research to improve clinical outcomes are particularly challenging as sizeable studies are hard to produce. By improving our knowledge about the molecular biology of sarcomas, we hope to identify new treatment strategies and targets for further drug development. We would like to invite manuscripts that aim to elucidate the pathophysiology and carcinogenesis of soft tissue and bone sarcomas and identify new arenas for sarcoma research. We are also particularly interested in manuscripts deciphering the mechanisms of putative targets for sarcoma treatments. By devoting a special issue just on soft tissue and bone sarcomas, we hope to display and bridge a critical mass of new and exciting research that can lead the way to improving cancer care for this cohort of patients.
Dr. Edwin Choy
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed Open Access quarterly journal published by MDPI.
- bone tumor
- drug development
- connective tissue oncology
Cancers 2014, 6(1), 112-127; doi:10.3390/cancers6010112
Received: 20 October 2013; in revised form: 17 December 2013 / Accepted: 18 December 2013 / Published: 14 January 2014| PDF Full-text (659 KB) | HTML Full-text | XML Full-text
Cancers 2013, 5(3), 890-900; doi:10.3390/cancers5030890
Received: 20 May 2013; in revised form: 20 May 2013 / Accepted: 18 June 2013 / Published: 15 July 2013| Cited by 1 | PDF Full-text (274 KB) | HTML Full-text | XML Full-text
Cancers 2013, 5(2), 529-549; doi:10.3390/cancers5020529
Received: 21 March 2013; in revised form: 16 April 2013 / Accepted: 2 May 2013 / Published: 10 May 2013| Cited by 2 | PDF Full-text (362 KB) | HTML Full-text | XML Full-text
Review: Lost in Translation: Ambiguity in Nerve Sheath Tumor Nomenclature and Its Resultant Treatment Effect
Cancers 2013, 5(2), 519-528; doi:10.3390/cancers5020519
Received: 4 March 2013; in revised form: 9 April 2013 / Accepted: 3 May 2013 / Published: 8 May 2013| PDF Full-text (863 KB) | HTML Full-text | XML Full-text
Cancers 2013, 5(2), 418-429; doi:10.3390/cancers5020418
Received: 16 February 2013; in revised form: 25 March 2013 / Accepted: 6 April 2013 / Published: 11 April 2013| PDF Full-text (521 KB) | HTML Full-text | XML Full-text
Cancers 2013, 5(2), 404-417; doi:10.3390/cancers5020404
Received: 19 February 2013; in revised form: 19 March 2013 / Accepted: 3 April 2013 / Published: 11 April 2013| PDF Full-text (907 KB) | HTML Full-text | XML Full-text
Cancers 2013, 5(2), 372-403; doi:10.3390/cancers5020372
Received: 16 February 2013; in revised form: 22 March 2013 / Accepted: 26 March 2013 / Published: 8 April 2013| PDF Full-text (1254 KB) | HTML Full-text | XML Full-text
Review: Hypoxia-Inducible Factors: Mediators of Cancer Progression; Prognostic and Therapeutic Targets in Soft Tissue Sarcomas
Cancers 2013, 5(2), 320-333; doi:10.3390/cancers5020320
Received: 23 January 2013; in revised form: 12 March 2013 / Accepted: 26 March 2013 / Published: 2 April 2013| Cited by 3 | PDF Full-text (382 KB) | HTML Full-text | XML Full-text
Article: Nuclear DNA-Content in Mesenchymal Lesions in Dogs: Its Value as Marker of Malignancy and Extent of Genomic Instability
Cancers 2012, 4(4), 1300-1317; doi:10.3390/cancers4041300
Received: 25 October 2012; in revised form: 16 November 2012 / Accepted: 26 November 2012 / Published: 3 December 2012| PDF Full-text (640 KB) | HTML Full-text | XML Full-text
Last update: 25 September 2012